CSM Technology   Contact Anti-inflammatory
		The Company's third application focuses on localized anti-inflammatory effects. This Cell Signal Modulation ("CSM") technology has been shown in animal and cell culture models to substantially reduce the production of inflammatory cell signal cytokines TNF-a and IL-1, which are linked to many serious diseases and loss of tissue function. Use of investment proceeds would also be used in this project to finance completion of mechanism-of-action studies and additional, clinically relevant, animal studies. Targeted clinical conditions are inflammatory skin conditions like psoriasis and post-surgical inflammatory complications, such as adhesions and systemic inflammatory response syndrome ("SIRS").